Cantor Fitzgerald is a New York City-based venture capital firm.
Cantor Fitzgerald key facts (as of )
Is this your firm? Get featured or correct your listing →
We track Cantor Fitzgerald but have little verified detail yet.
Strategy
Geographies
New York City, United States
Value Add Research
Latest Pulse
- Sep 21, 2026Electra Therapeutics Closes First Day Down 12%Electra Therapeutics priced its upsized IPO at $15 a share for roughly $350 million, then closed its first trading day on Nasdaq down nearly 12% at $13.25 -- a rockier debut than the biotech IPO market's recent run of first-day pops.→
- Aug 26, 2026Starfighters Space Amends S-1 After PIPE ClosingStarfighters Space, which flies a fleet of seven Mach 2+ F-104 fighter jets from Cape Canaveral toward a suborbital launch license, filed an S-1/A registering resale shares from a May 2026 PIPE placed by Cantor Fitzgerald.→
- Jul 27, 2026Apnimed Launches $150M IPO for Sleep Apnea PillApnimed launched a $150-160 million IPO for a pill that could become the first FDA-approved treatment for obstructive sleep apnea.→
Cantor Fitzgerald FAQ
Where is Cantor Fitzgerald based?
Cantor Fitzgerald is headquartered in New York City, United States and was founded in 1945, according to Wikidata.